文献速递血液净化与透析肾移植慢性肾脏病

英国启动肾脏替代治疗的年轻成人临床流行病学:基于英国肾脏登记系统15年数据的表现、管理与生存分析

The clinical epidemiology of young adults starting renal replacement therapy in the UK: presentation, management and survival using 15 years of UK Renal Registry data.
PubMed 文献 · Nephrol Dial Transplant · 2018-01-01

该研究合并英国肾脏登记系统儿科与成人数据库,纳入1999至2008年启动肾脏替代治疗的11–30岁患者3370例,随访5年。队列中52%以血液透析起始,78%接受移植,8%死亡;透析未列入移植等待者死亡风险显著高于移植者(HR 16.6,95%CI 10.8–25.4,P<0.0001),糖尿病较肾小球肾炎死亡风险升高(HR 4.03,95%CI 2.71–6.01,P<0.0001)。

要点

  • 年轻成人启动肾脏替代治疗时超半数以血液透析起始,近八成最终接受移植。
  • 5年内约一成未列入移植等待,其死亡风险约为移植者的20倍。
  • 糖尿病作为原发肾病在年轻成人中常见,且与死亡风险升高相关。

核心结论

  • 研究强调年轻成人中血液透析使用频繁,移植列入和糖尿病对预后至关重要。
  • 队列中超过半数年轻成人以血液透析启动肾脏替代治疗。
  • 5年内十分之一年轻成人未列入移植等待,其死亡可能性约为移植者的20倍。
  • 糖尿病作为原发肾脏病在年轻成人中常见,并与死亡风险升高相关。
  • 总体而言,近十分之一年轻成人在启动肾脏替代治疗后5年内死亡。

研究设计与样本

  • 合并英国肾脏登记系统儿科与成人数据库,纳入1999至2008年启动肾脏替代治疗的11–30岁患者,按年龄组分层并随访5年。
  • 队列共3370例,58%为男性,79%为白人,29%患有肾小球肾炎。

主要发现

  • 52%以血液透析启动肾脏替代治疗;78%接受移植(18%为抢先移植,61%为第二治疗方式);11%未列入移植等待。
  • 移植时机随年龄组变化;11–<16岁 deceased:living 供肾移植比为2:1,其他年龄组为1:1。
  • deceased donor 移植中位等待时间从<16岁的6个月至≥21岁的17个月不等。
  • 总体8%死亡;透析且未列入移植等待者较移植者死亡风险升高(HR 16.6,95%CI 10.8–25.4,P<0.0001)。
  • 糖尿病较肾小球肾炎死亡风险升高(HR 4.03,95%CI 2.71–6.01,P<0.0001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Clinical epidemiology data for young adults on renal replacement therapy (RRT) are lacking. While mostly transplanted, they have an increased risk of graft loss during young adulthood. METHODS: We combined the UK Renal Registry paediatric and adult databases to describe patient characteristics, transplantation and survival for young adults. We grouped patients 11-30 years of age starting RRT from 1999 to 2008 by age band and examined their course during 5 years of follow-up. RESULTS: The cohort (n = 3370) was 58% male, 79% white and 29% had glomerulonephritis. Half (52%) started RRT on haemodialysis (HD). Most (78%) were transplanted (18% pre-emptive, 61% as second modality); 11% were not listed for transplant. Transplant timing varied by age group. The deceased:living donor kidney transplant ratio was 2:1 for 11-<16 year olds and 1:1 otherwise. Median deceased donor transplant waiting times ranged from 6 months if <16 years of age to 17 months if ≥21 years. Overall 8% died, with being on dialysis and not transplant listed versus transplanted {hazard ratio [HR] 16.6 [95% confidence interval (CI) 10.8-25.4], P < 0.0001} and diabetes versus glomerulonephritis [HR 4.03 (95% CI 2.71-6.01), P < 0.0001] increasing mortality risk. CONCLUSIONS: This study highlights the frequent use of HD and the importance of transplant listing and diabetes for young adults. More than half the young adults in our cohort started renal replacement therapy on HD. One in 10 young adults were not listed for transplant by 5 years and were ∼20 times more likely to die than those who were transplanted. Diabetes as a primary renal disease was common among young adults and associated with increased mortality. Overall, almost 1 in 10 young adults had died by 5 years from the start of RRT.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Hamilton AJ, Casula A, Ben-Shlomo Y, et al. The clinical epidemiology of young adults starting renal replacement therapy in the UK: presentation, management and survival using 15 years of UK Renal Registry data. Nephrol Dial Transplant. 2018. PMID: 28339838. doi:10.1093/ndt/gfw444

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。